Crossmark

7-Hydroxymitragynine (7-OH): Clinical Implications of a Potent, Unregulated Opioid Partial Agonist Derived from Kratom (Mitragyna speciosa)

Published Online: 2026-05-19

Authors

Kameg, Brayden
License Information

Text and Data Mining valid from 2026-05-19

Version of Record valid from 2026-05-19
More Information

Article History

Received: 6 March 2026

Accepted: 30 April 2026

First Online: 19 May 2026

Declarations

:

: No animal or human subjects were used by the authors in this study.

: The authors declare no competing interests.

Document is current